WallStreetZenWallStreetZen

NASDAQ: ENTX
Entera Bio Ltd Stock Forecast, Predictions & Price Target

Analyst price target for ENTX

Based on 1 analyst offering 12 month price targets for Entera Bio Ltd.
Min Forecast
$10.00+395.05%
Avg Forecast
$10.00+395.05%
Max Forecast
$10.00+395.05%

Should I buy or sell ENTX stock?

Based on 1 analyst offering ratings for Entera Bio Ltd.
Buy
Strong Buy
0 analysts 0%
Buy
1 analysts 100%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their ENTX stock forecasts and price targets.

ENTX stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2024-06-05

1 of 1

Forecast return on equity

Is ENTX forecast to generate an efficient return?
Company
N/A
Industry
76.61%
Market
81.23%

Forecast return on assets

Is ENTX forecast to generate an efficient return on assets?
Company
N/A
Industry
31.22%

ENTX earnings per share forecast

What is ENTX's earnings per share in the next 2 years based on estimates from 1 analyst?
Avg 1 year Forecast
-$0.25
Avg 2 year Forecast
-$0.54

ENTX vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
ENTX$2.02$10.00+395.05%Buy
BCAB$1.51$6.00+297.35%Buy
MRNS$1.33$10.50+689.47%Buy
LPTX$1.92$7.25+277.60%Buy
MIST$1.38$15.00+986.96%Strong Buy

Entera Bio Stock Forecast FAQ

Is Entera Bio Stock a good buy in 2024, according to Wall Street analysts?

The consensus among 1 Wall Street analyst covering (NASDAQ: ENTX) stock is to Buy ENTX stock.

Out of 1 analyst, 0 (0%) are recommending ENTX as a Strong Buy, 1 (100%) are recommending ENTX as a Buy, 0 (0%) are recommending ENTX as a Hold, 0 (0%) are recommending ENTX as a Sell, and 0 (0%) are recommending ENTX as a Strong Sell.

If you're new to stock investing, here's how to buy Entera Bio stock.

What is ENTX's earnings growth forecast for 2024-2025?

(NASDAQ: ENTX) Entera Bio's forecast annual earnings growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast earnings growth rate of 14.34%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 18.95%.

Entera Bio's earnings in 2024 is -$8,716,000.On average, 1 Wall Street analyst forecast ENTX's earnings for 2024 to be -$8,946,327, with the lowest ENTX earnings forecast at -$8,946,327, and the highest ENTX earnings forecast at -$8,946,327.

In 2025, ENTX is forecast to generate -$19,324,067 in earnings, with the lowest earnings forecast at -$19,324,067 and the highest earnings forecast at -$19,324,067.

What is ENTX's forecast return on equity (ROE) for 2024-2027?

(NASDAQ: ENTX) forecast ROE is N/A, which is considered weak.

What is ENTX's Price Target?

According to 1 Wall Street analyst that have issued a 1 year ENTX price target, the average ENTX price target is $10.00, with the highest ENTX stock price forecast at $10.00 and the lowest ENTX stock price forecast at $10.00.

The Wall Street analyst predicted that Entera Bio's share price could reach $10.00 by Jun 5, 2025. The average Entera Bio stock price prediction forecasts a potential upside of 395.05% from the current ENTX share price of $2.02.

What is ENTX's Earnings Per Share (EPS) forecast for 2024-2025?

(NASDAQ: ENTX) Entera Bio's current Earnings Per Share (EPS) is -$0.28. On average, analysts forecast that ENTX's EPS will be -$0.25 for 2024, with the lowest EPS forecast at -$0.25, and the highest EPS forecast at -$0.25. In 2025, ENTX's EPS is forecast to hit -$0.54 (min: -$0.54, max: -$0.54).

What is ENTX's forecast return on assets (ROA) for 2024-2027?

(NASDAQ: ENTX) forecast ROA is N/A, which is lower than the forecast US Biotechnology industry average of 31.22%.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.